SCHEMBL25204894

SCHEMBL25204894

CC(C)(C)c1ccc(Nc2ccc(CNO)cc2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.36
▸ THRB P10828 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RORC P51449 2/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ KIF11 P52732 2/20 0.32
▸ EPHX2 P34913 1/20 0.32
▸ NR1H4 Q96RI1 1/20 0.32
▸ PTPN7 P35236 1/20 0.32
▸ DUSP3 P51452 1/20 0.32
▸ KCNH3 Q9ULD8 1/20 0.32
▸ SOS1 Q07889 1/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25183891 0.76 CA1 (0.49) EPHX2NR1H4
SCHEMBL25190165 0.75 RIPK1 (0.44) CFTRRORC
SCHEMBL31053489 0.75 KIF11 (0.44) THRBIDO1HPGDMAPTKIF11
SCHEMBL25183900 0.75 KIF11 (0.44) THRBIDO1HPGDMAPTKIF11
SCHEMBL25196241 0.73 GAA (0.49) THRBIDO1HPGDMAPTNOS1
SCHEMBL25187893 0.73 KIF11 (0.46) CFTRKIF11EPHX2NR1H4SOS1
SCHEMBL30422479 0.73 THRB (0.42) THRBIDO1HPGDMAPTMAPK1
SCHEMBL25194892 0.72 HTT (0.44) CFTRHPGDMAPTSOS1DHODH
SCHEMBL25190397 0.70 THRB (0.39) THRBIDO1HPGDMAPTMAPK1
SCHEMBL13528298 0.70 CFTR (0.40) CFTRMAPTMAPK1KIF11NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 CFTR 2526/4885THRB 4031/4885IDO1 1444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback